New pill tested to tame unpredictable chronic hives

NCT ID NCT07005713

Summary

This is an early-stage study to test the safety and effects of a new oral drug called BGB-16673 in adults with chronic spontaneous urticaria (CSU), a condition causing unpredictable hives and itching. The study will involve about 34 participants who will receive either the drug or a placebo to see how their bodies process it and if it helps reduce their symptoms. The main goals are to check for side effects and measure how the drug behaves in the body, while also tracking changes in hive and itch severity.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chengdu Second Peoples Hospital

    Chengdu, Sichuan, 610021, China

  • Dermatology Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Hangzhou First Peoples Hospital

    Hangzhou, Zhejiang, 310006, China

  • Peking University Third Hospital

    Beijing, Beijing Municipality, 100000, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, 630014, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, 325000, China

  • Union Hospital of Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430022, China

  • Xiangya Hospital of Central South University

    Changsha, Hunan, 410008, China

Conditions

Explore the condition pages connected to this study.